History and future of RNA medicines

Area of Science:

• Biotechnology and Pharmaceutical Sciences
• Molecular Medicine

Background:

• RNA therapeutics represent a versatile class of drugs targeting a wide range of diseases.
• They offer advantages over traditional therapies, including faster development and simplified manufacturing.
• The field includes modalities like antisense oligonucleotides, small interfering RNAs, microRNAs, messenger RNAs (mRNAs), and aptamers.

Purpose of the Study:

• To highlight the advantages and diverse applications of RNA therapeutics.
• To discuss the impact of messenger RNA (mRNA) vaccine success on the broader field of RNA therapeutics.
• To explore the potential of RNA-based treatments for conditions with limited therapeutic options.

Main Methods:

• Review of existing literature on RNA therapeutic modalities.
• Analysis of the comparative advantages of RNA-based drugs versus traditional pharmaceuticals.
• Examination of recent clinical translation successes, particularly mRNA vaccines.

Main Results:

• RNA therapeutics demonstrate faster, less expensive development and simplified manufacturing compared to conventional drugs.
• The success of mRNA vaccines has spurred significant research and clinical translation for other RNA approaches.
• RNA therapeutics show promise for treating chronic wounds, metastatic melanoma, and autoimmune/genetic skin diseases.

Conclusions:

• RNA therapeutics are a rapidly advancing field with broad therapeutic potential.
• The versatility and advantages of RNA modalities position them as key future medicines.
• Further research and clinical translation are expected to expand the impact of RNA therapeutics across numerous diseases.